Display options
Cite
Pala L, Conforti F. The effect of patient sex on the efficacy and safety of anticancer immunotherapy. Expert Opin Drug Saf. 2021;20(12):1535-1544doi: 10.1080/14740338.2021.1939672.
Pala, L., & Conforti, F. (2021). The effect of patient sex on the efficacy and safety of anticancer immunotherapy. Expert opinion on drug safety, 20(12), 1535-1544. https://doi.org/10.1080/14740338.2021.1939672
Pala, Laura, and Conforti, Fabio. "The effect of patient sex on the efficacy and safety of anticancer immunotherapy." Expert opinion on drug safety vol. 20,12 (2021): 1535-1544. doi: https://doi.org/10.1080/14740338.2021.1939672
Pala L, Conforti F. The effect of patient sex on the efficacy and safety of anticancer immunotherapy. Expert Opin Drug Saf. 2021 Dec;20(12):1535-1544. doi: 10.1080/14740338.2021.1939672. Epub 2021 Sep 01. PMID: 34468257.
Copy Download .nbib Format: NLM
Share it on

Expert Opin Drug Saf. 2021 Dec;20(12):1535-1544. doi: 10.1080/14740338.2021.1939672. Epub 2021 Sep 01.

The effect of patient sex on the efficacy and safety of anticancer immunotherapy.

Expert opinion on drug safety

Laura Pala, Fabio Conforti

Affiliations

  1. Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.

PMID: 34468257 DOI: 10.1080/14740338.2021.1939672

[No abstract available.]

Keywords: Cancer; dimorphism; efficacy; immune-related adverse events; immunotherapy; safety; sex

Publication Types